WNT Pathway clinical trials at UCSF

1 research study open to eligible people

The Wnt pathway is how cells send signals that control growth and repair. UCSF is running a study of a drug that targets the Wnt pathway in people with advanced or spread solid tumors. UCSF is tracking safety and how well the drug works.

Showing trials for

  • FOG-001 in Locally Advanced or Metastatic Solid Tumors

    open to eligible people ages 18 years and up

    The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors or in participants with familial adenomatous polyposis (FAP).

    San Francisco, California and other locations

Our lead scientists for WNT Pathway research studies include .

Last updated: